Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?

Serial In Vivo Intravascular Ultrasound-Based Echogenicity Changes of Everolimus-Eluting Bioresorbable Vascular Scaffold During the First 12 Months After Implantation

(2011) Salvatore Brugaletta et al.   JACC-Cardiovascular Interventions

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

(2011) Patrick W. Serruys et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Vascular restoration therapy: what should the clinical and angiographic measures for success be?

(2011) Ahmed Khattab et al.   EuroIntervention

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

(2011) Salvatore Brugaletta et al.   EuroIntervention

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

(2010) Patrick W. Serruys et al.   CIRCULATION

Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model

(2010) Yoshinobu Onuma et al.   CIRCULATION

Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold

(2010) Salvatore Brugaletta et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Monitoring In Vivo Absorption of a Drug-Eluting Bioabsorbable Stent With Intravascular Ultrasound-Derived Parameters

(2010) Nico Bruining et al.   JACC-Cardiovascular Interventions

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

(2010) Takayuki Okamura et al.   EuroIntervention

Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques

(2009) S Lavi et al.   HEART

Effects of Statin Treatments on Coronary Plaques Assessed by Volumetric Virtual Histology Intravascular Ultrasound Analysis

(2009) Myeong-Ki Hong et al.   JACC-Cardiovascular Interventions

Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress

(2009) Lakshmana K. Pendyala et al.   JACC-Cardiovascular Interventions

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

(2009) Patrick W Serruys et al.   LANCET

Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

(2008) Patrick W. Serruys et al.   CIRCULATION

Interference of Drug-Eluting Stents With Endothelium-Dependent Coronary Vasomotion

(2008) Michalis Hamilos et al.   Circulation-Cardiovascular Interventions

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

(2008) John A Ormiston et al.   LANCET